634 related articles for article (PubMed ID: 18063086)
1. Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism.
Iacobone M; Barzon L; Porzionato A; Masi G; Macchi V; Marino F; Viel G; Favia G
Surgery; 2007 Dec; 142(6):984-91; discussion 984-91. PubMed ID: 18063086
[TBL] [Abstract][Full Text] [Related]
2. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
Sarquis MS; Silveira LG; Pimenta FJ; Dias EP; Teh BT; Friedman E; Gomez RS; Tavares GC; Eng C; De Marco L
Surgery; 2008 May; 143(5):630-40. PubMed ID: 18436011
[TBL] [Abstract][Full Text] [Related]
3. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
4. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
5. Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism.
Carneiro DM; Irvin GL; Inabnet WB
Surgery; 2002 Dec; 132(6):1050-4; discussion 1055. PubMed ID: 12490854
[TBL] [Abstract][Full Text] [Related]
6. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
7. Recurrent or persistent hyperparathyroidism.
Wells SA; Debenedetti MK; Doherty GM
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N158-62. PubMed ID: 12412795
[TBL] [Abstract][Full Text] [Related]
8. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
Cetani F; Pardi E; Ambrogini E; Lemmi M; Borsari S; Cianferotti L; Vignali E; Viacava P; Berti P; Mariotti S; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2006 Feb; 64(2):146-52. PubMed ID: 16430712
[TBL] [Abstract][Full Text] [Related]
9. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
Endocr Relat Cancer; 2007 Jun; 14(2):501-12. PubMed ID: 17639063
[TBL] [Abstract][Full Text] [Related]
10. Does histopathology predict parathyroid hypersecretion and influence correctly the extent of parathyroidectomy in patients with sporadic primary hyperparathyroidism?
Carneiro-Pla DM; Romaguera R; Nadji M; Lew JI; Solorzano CC; Irvin GL
Surgery; 2007 Dec; 142(6):930-5; discussion 930-5. PubMed ID: 18063078
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
12. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
[TBL] [Abstract][Full Text] [Related]
13. Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy.
Kebebew E; Duh QY; Clark OH
Arch Surg; 2004 Sep; 139(9):974-7. PubMed ID: 15381615
[TBL] [Abstract][Full Text] [Related]
14. [Unilateral neck exploration in primary hyperparathyroidism].
Friedrich J; Krause U; Saller B; Eigler FW
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1157-60. PubMed ID: 9574364
[TBL] [Abstract][Full Text] [Related]
15. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.
Kim HK; Oh YL; Kim SH; Lee DY; Kang HC; Lee JI; Jang HW; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
Head Neck; 2012 Feb; 34(2):201-6. PubMed ID: 21717519
[TBL] [Abstract][Full Text] [Related]
16. The anatomy of primary hyperparathyroidism.
Thompson NW; Eckhauser FE; Harness JK
Surgery; 1982 Nov; 92(5):814-21. PubMed ID: 7135202
[TBL] [Abstract][Full Text] [Related]
17. Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease.
Tominaga Y; Tsuzuki T; Matsuoka S; Uno N; Sato T; Shimabukuro S; Goto N; Nagasaka T; Uchida K
World J Surg; 2008 May; 32(5):815-21. PubMed ID: 18338208
[TBL] [Abstract][Full Text] [Related]
18. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
[TBL] [Abstract][Full Text] [Related]
19. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
[TBL] [Abstract][Full Text] [Related]
20. Surgical anatomy of hyperparathyroidism.
Hooghe L; Kinnaert P; Van Geertruyden J
Acta Chir Belg; 1992; 92(1):1-9. PubMed ID: 1553842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
